FDA recall Z-2086-2026

DFI Co., Ltd. · Class II · device

Product

Uric Acid in vitro diagnostic test REF: 31H0P

Reason for recall

The devices were distributed without required FDA premarket clearance or approval.

Distribution

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

Key facts

Status
Ongoing
Initiation date
2026-04-02
Report date
2026-05-13
Voluntary/Mandated
Voluntary: Firm initiated
Location
Gimhae, Korea (the Republic of)

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2086-2026